Atlas Trials

Nivolumab With Chemotherapy in Pleural Mesothelioma After Surgery

Clinical trial NCT04177953 · COMPLETED

Trial details

NCT number
NCT04177953
Sponsor
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Pleural Mesothelioma Malignant
Start date
2019-02-04
Primary completion
2025-01-30
Enrollment
92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.